Paradigm Biocapital Advisors LP JANX Holdings History
Paradigm Biocapital Advisors LP's Janux Therapeutics Inc Holding Summary
As of 2025-03-31, Paradigm Biocapital Advisors LP held 3.33 Mil shares of Janux Therapeutics Inc(JANX), totaling $89.91 Mil. This investment constitutes 4.12% of their stock portfolio, and Paradigm Biocapital Advisors LP now holds 5.63% of the outstanding Janux Therapeutics Inc(JANX) stock.
The initial trade took place in 2024Q2. And since then Paradigm Biocapital Advisors LP has made 3 purchases of JANX, at an average price of $48.06, for a total of 3.52 Mil shares. In addition, there have been 1 sales at an average price of $37.69 for 186,077.00 shares. Based on historical transaction data and JANX's current price of $26.38, Paradigm Biocapital Advisors LP's estimated gain on his JANX holdings is $-74.12 Mil, reflecting a -43.86% gain to date.
Paradigm Biocapital Advisors LP JANX ($26.38) Holding Chart
Paradigm Biocapital Advisors LP JANX ($26.38) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
